The integrated relationship between inflammation, obesity and cardiovascular disease is currently a subject of much research interest. These specific relationships, however, have not been studied in-depth in South African population groups in order to determine the role of ethnicity. It is known that Africans, compared to Caucasians, suffer from a high prevalence of hypertension. It was therefore hypothesized that the levels of inflammatory markers (high-sensitivity C-reactive protein (hsCRP), fibrinogen and leptin) are higher in Africans compared to Caucasians and are notably associated with cardiovascular dysfunction in Africans. Apparently healthy African (N ¼ 102) and Caucasian (N ¼ 115) women, matched for age and body mass index (BMI), were recruited. Leptin, hsCRP, fibrinogen and lipid levels, waist circumference (WC), BMI, systolic and diastolic blood pressure, cardiac output (CO), total peripheral resistance (TPR) and Windkessel compliance were measured. Results showed that the levels of leptin, hsCRP and fibrinogen were significantly higher (Po0.05) in the African women. The inflammatory markers correlated strongly with cardiovascular parameters, age and obesity (BMI, WC) in both groups, but after adjusting for age and obesity, none of the correlations were significant anymore. Multiple regression analyses (with leptin, hsCRP or fibrinogen as dependent variable) showed that only leptin levels of African women were explained by cardiovascular parameters (BP, TPR and CO). In conclusion, even though African women had significantly higher leptin, hsCRP, fibrinogen and blood pressure levels than Caucasian women, no cardiovascular parameters explained the variation in the inflammatory markers (except for leptin levels of African women).
Introduction
Various researchers have reported on the prevalence of the metabolic syndrome in different population groups around the world. 1, 2 The metabolic syndrome is described as a cluster of metabolismrelated conditions such as insulin resistance, hyperlipidaemia and central obesity. [1] [2] [3] Central obesity and comorbidities such as cardiovascular disease, including hypertension and coronary heart disease, are closely associated with the global prevalence of the metabolic syndrome. [4] [5] [6] Recent research has shown that adipocyte tissue itself is an endocrine organ capable of secreting various chemical messengers, affecting various metabolic and immunologic activities. 7, 8 Probably, the most well known of these messengers is leptin. Leptin indicates fat percentage, 9 but it is also a cytokine-like agent that has various physiological functions -including regulation of energy homeostasis, 10, 11 as well as reproductive development and function. 8, 10, 11 Leptin also plays a role in immunity and inflammation, by stimulating the secretion of various inflammatory markers. 5, 9 It is also implicated in cardiovascular dysfunction -including atherosclerosis and hypertension. 6, 9, 12, 13 Obesity is also associated with inflammation, 5, 14 in fact various acute phase proteins correlate well with the level of obesity. These inflammatory markers include among others, C-reactive protein (CRP) 5, 9, 15 and fibrinogen. 16 It is then no surprise that these markers' levels have also been found to correlate with leptin. 17, 18 These same inflammatory markers are also associated with the risk for and presence of cardiovascular disease. [19] [20] [21] [22] Fibrinogen is especially associated with atherosclerosis and vascular occlusive pathologies. 20, 23 In the South African population, hypertension is more prevalent in urban black Africans compared to Caucasians, Indians and those of mixed origin. 24, 25 This is also the case in African Americans and Caribbean Africans living in the UK. 26 Seedat 24 reported that obesity is an important contributor to hypertension in black sub-Saharan African women. Various studies have also been carried out to investigate the prevalence of inflammatory markers in different ethnic groups. Albert et al. 27 found significantly higher levels of CRP in African American women than in Caucasian women. In contrast to this research, Heald et al. 28 found that CRP and ethnicity are not independently associated with one another. The same controversy is found regarding leptin and ethnicity. Some studies show that leptin is not related to ethnicity, 29, 30 whereas others do. 31 The question therefore arises whether there is a difference in the levels of inflammation in black Africans compared to Caucasians. If so, this could at least partly explain the relatively high prevalence of hypertension in the African group. 24 We hypothesize that the levels of inflammatory markers (in this study CRP, fibrinogen and leptin) are higher in Africans compared to Caucasians and are notably associated with cardiovascular dysfunction in Africans.
Materials and methods

Study design
The POWIRS study (Profiles of Obese Women with the Insulin Resistance Syndrome) consisted of two case-case-control studies, of which the first was performed on 102 apparently healthy African women. This study, as described below, was later repeated on a group of 115 Caucasian women. The individuals in these two groups were individually matched on the basis of age and body mass index (BMI). The African women were recruited from a government institution in the Potchefstroom district, North-West Province, South Africa. The Caucasian group was recruited from an urban area in the Potchefstroom district. For a complete description of all procedures, measurements and questionnaires performed during this study refer to Schutte et al. 32 Participants between the ages of 20 and 50 years were recruited on the basis of their BMI. The total group could therefore be classified in three different approximately equally distributed groups, as described by the World Health Organization (WHO): 4 lean with BMI of 18.5-24.9 kg/m 2 ; overweight (i.e., pre-obese) with BMI of 25.0-29.9 kg/m 2 and obese with BMI X30.0 kg/m 2 . The exclusion criteria were as follows: pregnancy, lactation, diabetes mellitus, treatment for mental or neurological diseases requiring the use of any medication and an oral temperature (infrared) higher than 371C.
After the experimental procedure and set-up was explained, all participants gave written informed consent for their participation. The study was also approved by the Ethics Committee of the North-West University.
All data collection took place at a Metabolic Unit Facility (consisting of 10 single bedrooms, two bathrooms, a kitchen and living room) at the Potchefstroom campus of the North-West University. Participants received a light supper (excluding alcohol and caffeine) at 2000 hours and fasted overnight. They went to sleep before 2300 hours. This was carried out to ensure a stable and resting blood pressure the following morning.
Using the Finometer device, cardiovascular measurements were taken the next morning before breakfast, between 0600 and 0800 hours while the subjects were lying in the Fowler's position. Subjects were not permitted to walk around or eat or drink anything (except water) before the readings were completed. After the Finometer recordings, fasting blood samples were collected from the antebrachial vein using sterile winged infusion sets and syringes. For serum samples, the blood was drawn and left to clot. For the determination of fibrinogen, 10 ml citrated blood was drawn. The clotted and citrated blood samples were centrifuged at 3500 r.p.m. for 10 min at 101C to yield serum and plasma, respectively. Serum and plasma were divided into aliquots and stored at À821C until analysis.
The data collection in the African subjects was 
Anthropometric measurements
Measurements were taken of subjects in their underwear. Calibrated instruments and standard methods were used. 33 Maximum height was measured to the nearest 0.1 cm using the Invicta Stadiometer (IP 1465, UK). Weight was measured to the nearest 0.1 kg using the Precision Health Scale (A & D Company, Tokyo, Japan). During these measurements participants were required to stand erect, feet together, without voluntary contraction of the gluteal muscles. Waist circumference (WC) was measured using a Holtain unstretchable metal tape. Measurements were standardized and taken in triplicate.
Cardiovascular measurements
Cardiovascular parameters were monitored by making use of the Finometer device (FMS, Finapres Medical Systems, Amsterdam, the Netherlands). 34 This entailed a 7-min continuous recording of each subject's cardiovascular parameters under resting, yet awake, conditions. After the first 2 min, the upper arm pressure was calibrated with the finger pressure for each individual subject (i.e. return-to-flow systolic calibration). This was performed to optimize the accuracy of the readings taken. The last 2 min of each recording was used to calculate the average systolic and diastolic pressure (SBP and DBP). Data files were later extracted from the device's hard drive and processed by making use of the Beatscope 1.1 software. The following cardiovascular parameters were obtained: SBP, DBP, cardiac output (CO), total peripheral resistance (TPR) and Windkessel compliance (Cwk).
Biochemical analysis
Plasma fibrinogen levels were measured using the ACL-200 automated coagulation analyzer and reagents from Instrumentation Laboratories (Milan, Italy). A modified method of Clauss 35 was employed to obtain fibrinogen measurements. Serum leptin was obtained with a 125 I IRMA kit (Diagnostic Systems Laboratories Inc., Texas, USA, Cat. No. DSL-23100). The high-sensitivity C-Reactive Protein Kit from Immage Immunochemistry Systems (Cat. No. 474630, Beckman Coulter Inc., Fullerton, CA, USA) was used to measure high-sensitivity C-reactive protein (hsCRP) levels. Lipid levels were measured on a Vitros DT60 II Chemistry System with Vitros DT slides.
Statistical analysis
All statistical analyses were performed using Statistica version 7 (StatSoft Inc., Tulsa, OK, USA, 2004) software. Parameters that were not normally distributed were logarithmically transformed. An independent sample t-test was carried out to compare the two ethnic groups in terms of age, BMI, WC, cardiovascular variables and inflammatory markers. Using analysis of covariance (ANCOVA), the two ethnic groups were again compared to test for significant differences while adjusting for WC (Table 1) .
Correlations between inflammatory markers (leptin, hsCRP and fibrinogen) and BMI, WC and cardiovascular parameters (SBP, DBP, CO, TPR, Cwk) were performed within each ethnic group (Table 2) . This was repeated after adjustments for age, BMI and WC. In order to test whether associations exist between the inflammatory markers and cardiovascular parameters while taking ethnicity into account, partial correlations were performed between inflammatory markers and cardiovascular parameters while adjusting for ethnicity (Table 3) .
Significant interaction terms were determined by 2 Â 2 ANCOVAs between inflammatory markers (leptin, hsCRP and fibrinogen) and ethnicity while adjusting for age, BMI and WC. Multiple regression analyses were performed with either hsCRP, fibrinogen or leptin as dependent variable, and with the following independent variables: ethnicity, age, BMI, WC, mean arterial pressure, CO, TPR, highdensity lipoprotein (HDL), triglycerides and the two remaining inflammatory markers (which would be hsCRP, fibrinogen or leptin) (Table 4) . Afterwards, similar multiple regression analyses were performed separately for each ethnic group (Table 5) . In order to compare the results of the regression analyses, Z-scores were determined for the three inflammatory markers. The following equation was used: Z ¼ (each value or data pointÀmean value)/s.d. Table 1 compares the subject characteristics of the African and Caucasian women. It is clear from this table that although the two groups had similar ages and BMIs, the blood pressure (and peripheral resistance) as well as all inflammatory marker levels (leptin, hsCRP and fibrinogen) were significantly higher in the African women. Despite a similarity in BMI between the two ethnic groups, the African group had lower WC values (Pp0.05) than the Caucasian group. It should also be noted that the African women had significantly lower height and weight values than the Caucasian women.
Results
Irrespective of adjustment for WC, the same trends are still present in this comparison. It is also evident from this table that although the BMI interquartile ranges were quite similar between the ethnic groups, the ranges of all quartiles of the inflammatory markers were higher for the African women.
To ascertain the associations between inflammatory markers and cardiovascular function in the two ethnic groups, correlations were performed between the inflammatory markers (hsCRP, fibrinogen and leptin) and age, obesity markers (BMI, WC) and the cardiovascular parameters in each ethnic group ( Table 2 ). The inflammatory markers showed significant strong correlations with obesity markers (BMI, WC) and cardiovascular parameters in both ethnic groups. However, the Caucasian women showed more and stronger correlations between cardiovascular parameters, for example, strong positive correlations between leptin and Cwk and a negative correlation with TPR. Also, only Caucasian women showed strong correlations of hsCRP with Cwk (r ¼ 0.35) and TPR (r ¼ À0.34), and fibrinogen with DBP (r ¼ 0.20) and Cwk (r ¼ 0.31). In both ethnic groups, consistent strong positive inter-correlations were obtained between leptin, hsCRP and fibrinogen (ranging from r ¼ 0.39 to r ¼ 0.69).
After adjustments for age, BMI and WC, all correlations between the inflammatory markers and cardiovascular parameters became weak and nonsignificant when performed separately in each ethnic group. Only the inter-correlations between leptin, hsCRP and fibrinogen remained significant in both groups, but these correlations were much weaker than before the adjustments.
In order to determine the associations between the inflammatory markers and cardiovascular para- meters, irrespective of ethnicity, partial correlations were performed between either leptin, hsCRP or fibrinogen and the cardiovascular parameters, while adjusting for ethnicity (Table 3) . These results showed that although all correlations were statistically significant (Po0.05), many were quite weak, especially the associations with fibrinogen. The strongest correlations were shown for CO with the various inflammatory markers. Significant interaction terms for ethnicity and all three inflammatory markers were found, that is, for leptin (F(1,217) ¼ 24.52; Po0.001), hsCRP (F(1,217) ¼ 5.88; P ¼ 0.016) and fibrinogen (F(1,217) ¼ 58.88; Po0.001). Results of the multiple regression analyses with either leptin, hsCRP or fibrinogen as dependent variable are shown in Table 4 , with ethnicity included as independent variable. Results showed that variation of both leptin and fibrinogen were significantly explained by ethnicity (among others). Although variations of all inflammatory markers were explained by the other inflammatory markers, only fibrinogen variation was strongly explained by cardiovascular parameters, especially TPR (but also CO). Markers of obesity (BMI and WC) played more significant roles in explaining the variations of leptin and hsCRP.
When multiple regression analyses were performed separately in each ethnic group (Table 5) , it was evident that the leptin levels of the African women were mostly explained by obesity (BMI), cardiovascular parameters (mean BP, CO, TPR) and hsCRP, whereas leptin levels of Caucasian women r-value P-value r-value P-value r-value P-value r-value P-value r-value P-value r-value P-value were mostly explained by obesity only (BMI, WC). None of the other inflammatory markers (hsCRP and fibrinogen) were significantly explained by cardiovascular parameters in any ethnic group, and were mostly explained by the other inflammatory markers. In the Caucasian women, the variation in hsCRP was also explained by obesity (BMI, WC) and lipids (HDL and triglycerides).
Discussion
Our research group and others have reported on the prevalence of increased blood pressure in Africans compared to other ethnic groups in South Africa. 24, 25 Owing to the well-known association between inflammatory markers and increased risk for cardiovascular disease, 36 the first hypothesis of the present study consequently stated that the levels of inflammatory markers (hsCRP, fibrinogen and leptin) are higher in African compared to Caucasian women. African and Caucasian women were then individually matched according to BMI and age to test this hypothesis. Interestingly, the results of this study showed clearly that the levels of all three markers were significantly higher in the African group (Table 1) , also after adjustment for central obesity (WC). Furthermore, higher levels of blood pressure (characterized by higher levels of vascular resistance (TPR), lower Cwk and CO) were also observed in the African group, thereby supporting the literature. 24, 25 It is also evident from the multiple regression analysis ( Table 4 ) that ethnicity significantly predicts or describe the levels of especially leptin and fibrinogen in the combined (African and Caucasian) group. This result also shows that ethnicity seems to play an important role in differentiating between the levels of the inflammatory markers.
However, before this hypothesis can be accepted, the possible confounding role of different levels of adiposity should be taken into account. Even though the two groups were matched for BMI, it is clear from Table 1 that the groups differed significantly regarding central obesity (WC), as well as weight and height. Overall, the African women were significantly shorter, weighed less and had a significantly lower WC. It is known that adipose tissue is not a homogeneous tissue, and characteristics between depots and even between cells in different parts of the same depot differ within and between individuals. 37 Also, perivascular fat tissue may be especially detrimental as it contributes to systemic low-grade inflammation associated with obesity and may also interact in an autocrine/ paracrine manner with the endothelial cells and perivascular smooth muscle fibres, thereby contributing to the endothelial dysfunction, which has often been associated with markers of inflammation. 37 Whether these groups are comparable regarding level of adiposity could therefore be questioned, and it could therefore be possible that different levels of adiposity might explain the differences in inflammation between the African and Caucasian women (not necessarily genetic or other environmental factors). The first hypothesis is therefore accepted, but with caution.
The second hypothesis of this study stated that the levels of inflammatory markers are notably associated with cardiovascular dysfunction in Africans. Our research group has recently shown that the leptin levels of obese Caucasian women are favourably associated with vascular function, but this was not evident in obese African women. 31 Even though the results of the correlations (Table 2 ) of the present study showed strong relationships between inflammatory markers and cardiovascular parameters in both ethnic groups, results showed more and stronger correlations within the Caucasian women. Furthermore, adjustments for age and obesity resulted in no significant correlations between inflammatory markers and cardiovascular parameters. This is an important result, which indicates the strong and close inter-relationships between obesity, inflammation and cardiovascular disease. These relationships do not, however, describe clearly the cause-effect relationships. It is most probable, at least for the adipocytokines, that the inflammatory markers mediate the relationship between obesity and cardiovascular disease. 36, 38 To address the second hypothesis, further separate multiple regression analyses were performed for the ethnic groups (Table 5) to determine whether cardiovascular parameters explain variations in inflammation. And despite the significant correlations (obtained in Tables 2 and 3 ), the regression analyses showed no cardiovascular parameter explaining the variance of any of the inflammatory markers in either ethnic group, except for the leptin levels of the African women. In the latter case blood pressure, peripheral resistance and CO were strongly associated with leptin variance of African women. Contrasting arguments regarding leptin's vascular functions have been discussed in-depth by Rahmouni and Haynes, 39 and the results of this study contribute further to these contradictionsespecially as similar results were not obtained in the Caucasian women. Most noticeable in the multiple regression analyses, however, is the absence of significant cardiovascular contributions to the variances in hsCRP and fibrinogen in both ethnic groups.
The second hypothesis is therefore partially accepted based on the leptin results of the African women, but also partially rejected owing to the absence of cardiovascular contributions to the hsCRP and fibrinogen levels in the African women.
Based on the present results, the questions could now be asked why do these results not show significant associations between cardiovascular parameters and the inflammatory markers (in the multiple regression analyses; Table 5 ), and when adjusted for abdominal obesity (WC; Table 2 )? Also, why are the inflammatory marker levels so much higher in the African women compared to the Caucasian women?
Apart from the possible explanation earlier in the discussion regarding the Caucasian women who might have a different level of adiposity and fat distribution (being taller, heavier and have a higher WC than the African women), it should be taken into account that especially the obese African women who took part in this study suffered from very poor living conditions, very small incomes, low levels of education and high self-reported alcohol intake 32 (which differs widely from the living conditions of the Caucasian women). They also suffer from overnutrition. It has been hypothesized that overnutrition leads to obesity (an inflammatory condition), which in turn is associated with chronic activation of the immune system. 37 The very high levels of inflammatory markers in the African women might therefore be explained by a possible higher fat percentage compared to their Caucasian counterparts. A possibility also exists that high levels of inflammatory markers might mediate the detrimental effects of obesity, and this possibility needs to be investigated further.
It should also be remembered that an inflammatory marker such as hsCRP is a non-specific biomarker for inflammation. 40 Thus, even though the participants in this study were apparently healthy, it is possible that higher hsCRP levels might have been caused by other unknown inflammatory conditions.
As mentioned in the Materials and methods section, the time frames for data collection and biochemical analyses of the two ethnic groups differed. For the African women, the blood sampling took place during autumn, and was assayed during winter. During the following year, blood sampling of the Caucasian women was performed during winter, and was assayed during summer. These seasonal differences in data collection and assay dates could introduce bias and might have exerted some effects on the differences in the levels of the inflammatory markers. The extent of these possible effects is, however, uncertain, and it is unknown whether this might have influenced the results.
The relationship between cardiovascular disease and inflammation has been made quite clear in the literature. 36 Perhaps, it should also be considered when interpreting the results that the women participating in this study were relatively young (mean age of 31.3 years). And even though their inflammatory marker levels might have been elevated owing to obesity, there is also the possibility that established atherosclerosis and vascular dysfunction (and the associated inflammatory condition)
is not yet present in this group. The African women did show much higher vascular resistance than the Caucasian women, accompanied by much higher blood pressures, but it is not impossible that these conditions may be caused by another factor, such as sodium-sensitivity, which is a well-known condition for the African population. 41 To conclude, the African women in this study showed significantly higher levels of inflammatory markers than their Caucasian counterparts. Furthermore, cardiovascular parameters did not explain variances in inflammatory markers in either ethnic group (except for leptin levels of the African women). Whatever the explanation(s) for the results of this study might be, the authors believe that elucidation of the link between obesity, inflammation and cardiovascular disease remains a very worthwhile research endeavour -with many mediating and confounding factors to consider. It is also important to consider negative results not showing the expected associations, which might be an important aspect in understanding the role of inflammation in cardiovascular disease.
